Comparative study of routine diagnostic test, C-reactive protein with antithrombin III levels in diagnosis and prognosis of neonatal sepsis

Asruti R. Kacha; Saurabh Prasad; Panchshila Parmar

doi:10.18203/2349-3291.ijcp20183370

Authors

Asruti R. Kacha Department of Pediatric, Government Medical College, Vadodara, Gujarat, India
Saurabh Prasad Pearl Hospital, Sitabuldi, Nagpur, Maharastra, India
Panchshila Parmar Smt SCL General Hospital, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20183370

Keywords:

Antithrombin III, Neonate, Sepsis

Abstract

Background: Antithrombin III is a potent inhibitor of thrombin mediated vascular injury in the micro-circulation in severe sepsis. This endogenous anti-coagulant is rapidly depleted in the early phases of sepsis as a result of decreased synthesis, increased destruction and enhanced clearance by thrombin-antithrombin complexes. This study was conducted to evaluate the role of antithrombin III level in diagnosis and prognosis of culture proven neonatal sepsis as compared to conventional C-reactive protein.

Methods: This prospective study was conducted at a tertiary care hospital in 30 full term, appropriate for gestational age neonates who were admitted in neonatal intensive care unit for suspected sepsis.

Results: Out of 30 neonates suspected of sepsis in NICU, 22 turned out to be culture positive. Keeping antithrombin III cut off level ≤150 mg/L, 18 of those 22 culture positive neonates, had antithrombin III level ≤150 mg/L; sensitivity at ≤150mg/L was 81.82%. This was way higher than the 50% sensitivity of CRP, that was found in the study. (Only 11out of 22 culture positive neonates had positive CRP).

Conclusions: Antithrombin III level ≤ 150 mg/L is a good indicator for neonatal septicemia and helps to detect neonatal sepsis earlier and more accurately as compared to other conventional laboratory tests like CRP. It also predicts the prognosis of neonatal sepsis more precisely as compared to CRP.

Metrics

Metrics Loading ...

References

Bang AT, Bang RA, Bactule SB, Reddy HM, Deshmukh MD. Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India. Lancet. 1999;354:1955-61.

Stoll BJ. The global impact of neonatal infection. Clin Perinatal. 1997;24:1-21.

Fourrier F, Chopin C, Goudemand J, Hendryex S, Caron C, Rime A, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation compared patterns if antithrombin III, protein C and protein S deficiencies. Chest. 1992;101;816-23.

Lorente A, Garcia-Frade L, Landin L, de Pablo R, Torrado C, Renes E, et al. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest. 1993,103;1536-42.

Perry DJ, Aquired antithrombin deficiency in sepsis, British J Haematol. 2001;112:26-31.

Hisammuddin E, Hisam A, Raza G. Validity of C-reactive protein (CRP) for diagnosis of neonatal sepsis. Pak J Med Sci. 2015;31(3):527-31.

Benitz WE, Han MY, Madan A, Ramachandra P., Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998 Oct;102(4):E41.

Saito N, Takeda M, Harada T, Moroi R, Namiki M, Yaguchi A. Antithrombin III concentrate therapy may have an efficacy in sepsis. Critical Care. 2013 Apr;17(2):P60.

Harper PL, Park GR, Carrell RW. The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency. Transfus Med. 1996 Mar;6(1):45-50.

Niessen RW, Lamping RJ, Jansen PM, Prins MH, Peters M, Taylor JF, et al. Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons. Thrombosis Haemostasis. 1997 Sep;78(3):1088-92.

Seitz R, Wolf M, Egbring R, Radtke KP, Liesenfeld A, Pittner P, et al. Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections. Europ J Haematol. 1987 Mar;38(3):231-40.

Pelzer H, Schwartz A, Heimburger N. Determination of human T: AT III complex in plasma with an enzyme linked immunosorbent assay. Thromb Haemost. 1988;59:101-6.

Roman J, Velasco F, Fernandez F, Fernandez M, Villalba R, Rubio V. Coagulation, fibrinolytic and kallikrein systems in neonates with uncomplicated sepsis and septic shock. Hemostasis. 1993;23:142-8.

Lauterbach R, Pawlik D, Radziszewska R, Wozniak J, Rytlewski K. Antithrombin III and protein C levels in early recognition of late-onset sepsis in new-borns. European J Pediatr. 2006;165:585-9.

Mohamad H, Salah MH. The value of IL10, RANTES and antithrombin in prediction of sepsis induced DIC in preterm infants. Med J Cairo Univ. 2010;78(1):123-8.

El Beshlawy A, Alaraby I, Abou Hussein H, Abou-Elew HH. Study of protein C, protein S, and antithrombin III in new-borns with sepsis. Pediatr Crit Care Med. 2010;11(1):52-9.

Phillipe J, Offner F, Declerck PJ, Leroux-Rocks C, Vogelaers D. Fibrinolysis and coagulation in patients with infectious diseases and sepsis. Thromb Haemost. 1991;65:291-5.

Muntaha S, Akram W, Hassan F. Prognostic value of antithrombin III level in neonatal sepsis. J Rawalpindi Med Coll. 2016;20(3):202-5.

Hagag AA, Elmahdy HS, Ezzat AA. Prognostic value of plasma pro-adrenomedullin and antithrombin levels in neonatal sepsis. Indian Pediatr. 2011;48(6):471-3.

Hesselvik JC, Malm J, Dahlback B, Blomb M. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Hemost. 1991;65:126-31.

Eisele B, Heinrichs H, Delvos U, Lamy M, Thijs LG, Keinecke HO, et al. Antithrombin III in patients with severe sepsis. Intensive Care Med. 1998 Jul 1;24(7):663-72.